AVE Becomes the Acquirer, Rather Than the Acquired
Executive SummaryArterial Vascular Engineering Inc. recently acquired World Medical Manufacturing Corp., a small manufacturer of peripheral stents. The stent business is changing. No longer simply a cardiovascular device, stents are finding major new markets in the brain, abdomen and other peripheral applications.
You may also be interested in...
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.
Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug; FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.
FerGene bladder cancer therapy achieved a complete response in more than half of patients in its pivotal trial. The joint venture now looks to commercialization and potential expansion of indications.